









Markets
/
Stocks
/
nasdaq-irmd
/

IRadimed Corp

IRMD

86.395USD

+2.285+2.72%

Market hours （ET）Quotes delayed by 15 min

1.10BMarket Cap

51.88P/E TTM



IRadimed Corp

86.395

+2.285+2.72%

Overview Company Financials Analysis

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

Overview

Company

Financials

Analysis

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

TradingKey Stock Score of IRadimed Corp

Currency: USD Updated: 2025-11-03

Key Insights

The company's fundamentals are relatively very healthy. Its valuation is considered fairly valued,and institutional recognition is very high. Over the past 30 days, multiple analysts have rated the company as a Buy. The company is performing well in the stock market, with strong fundamentals and technicals supporting the current trend. The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

IRadimed Corp's Score

Industry at a Glance

Industry Ranking

25 / 210

Overall Ranking

93 / 4617

Industry

Healthcare Equipment & Supplies

Support & Resistance

No Data

Score Analysis

Current score

Previous score

Analyst Rating

Based on 2 analysts

Buy

Current Rating

82.500

Target Price

+7.41%

Upside Space

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

IRadimed Corp Highlights

StrengthsRisks

IRadimed Corporation develops, manufactures, markets and distributes magnetic resonance imaging (MRI) compatible medical devices and accessories and services. Its MRidium 3860+ MRI Compatible IV infusion pump system provides non-magnetic Intravenous (IV) infusion pump system that is specifically designed for safe use during MRI procedures. Its MRidium MRI compatible IV infusion pump system has been designed with a non-magnetic ultrasonic motor with non-ferrous parts and other special features to deliver anesthesia safely and predictably and other IV medications or fluids during various MRI procedures. Its IRadimed 3880 MRI Compatible patient vital signs monitoring system has been designed with non-magnetic components and other features to monitor a patient’s vital signs safely and accurately during various MRI procedures. The Company sells its products primarily to hospitals and acute care facilities. The IRADIMED 3880 system operates dependably in magnetic fields up to 30,000 gausses.

High Growth

The company's revenue has grown steadily over the past 3 years, averaging 37.41% year-on-year.

Growing

The company is in a growing phase, with the latest annual income totaling USD 73.24M.

High Profit Growth

The company's net income leads the industry, with the latest annual income totaling USD 73.24M.

High Dividend

The company is a high dividend payer, with the latest dividend payout ratio of 29.64%.

Overvalued

The company’s latest PE is 51.69, at a high 3-year percentile range.

Institutional Selling

The latest institutional holdings are 7.53M shares, decreasing 9.83% quarter-over-quarter.

Held by CI Select Canadian Equity Fund

Star Investor CI Select Canadian Equity Fund holds 27.00 shares of this stock.

Financial Health

Currency: USD Updated: 2025-11-03

The company's current financial score is 9.56, which is higher than the Healthcare Equipment & Supplies industry's average of 7.46. Its financial status is robust, and its operating efficiency is high. Its latest quarterly revenue reached 20.41M, representing a year-over-year increase of 13.84%, while its net profit experienced a year-over-year increase of 17.81%.

Score

Industry at a Glance

Previous score

9.56

Change



Financials

10.00

Key Metrics

Cash and cash equivalents

Total assets

Total liabilities

Free cash flow

No Data



Quality of Earnings

8.89

Key Metrics

Total revenue

Operating profit

Total assets

SG&A

No Data



Operational Efficiency

10.00

Key Metrics

Cash flow from operating activities

Income after tax

No Data



Growth Potential

10.00

Key Metrics

Cash flow from operating activities

Total revenue

No Data



Shareholder Returns

8.89

Key Metrics

Free cash flow

No Data

IRadimed Corp's Company Valuation

Currency: USD Updated: 2025-11-03

The company’s current valuation score is 5.26, which is lower than the Healthcare Equipment & Supplies industry's average of 7.19. Its current P/E ratio is 51.69, which is 0.00% below the recent high of 51.69 and 48.20% above the recent low of 26.78.

Score

Industry at a Glance

Previous score

5.26

Change

Valuation Dimensions

P/E

P/B

P/S

P/CF

Industry Ranking 25/210

No Data

Earnings Forecast

Currency: USD Updated: 2025-11-03

The company’s current earnings forecast score is 8.00, which is higher than the Healthcare Equipment & Supplies industry's average of 7.74. The average price target for IRadimed Corp is 82.50, with a high of 90.00 and a low of 75.00.

Score

Industry at a Glance

Previous score

8.00

Change

Support & Resistance

No Data

Analyst Rating

Based on 2 analysts

Buy

Current Rating

99.000

Target Price

+17.70%

Upside Space

Strong Buy

Buy

Hold

Sell

Strong Sell

Peer Comparison

Total

Median

Average

Company name

Ratings

Analysts

IRadimed Corp

IRMD

Boston Scientific Corp

BSX

Edwards Lifesciences Corp

Intuitive Surgical Inc

ISRG

Veeva Systems Inc

VEEV

Thermo Fisher Scientific Inc

TMO

...

Financial Forecasting

EPS

Revenue

Net Profit

EBIT

No Data

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated: 2025-11-03

The company’s current price momentum score is 9.54, which is higher than the Healthcare Equipment & Supplies industry's average of 6.72. Sideways: Currently, the stock price is trading between the resistance level at 88.96 and the support level at 75.30, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score

8.96

Change

0.58

Support & Resistance

No Data

Indicators



The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators

Sell(1)

Neutral(1)

Buy(4)

Indicators

Value

Direction

MACD(12,26,9)

0.833

Buy

RSI(14)

69.087

Neutral

STOCH(KDJ)(9,3,3)

70.718

Buy

ATR(14)

3.023

High Vlolatility

CCI(14)

193.902

Buy

Williams %R

7.092

Overbought

TRIX(12,20)

0.389

Sell

StochRSI(14)

100.000

Buy

Moving Average

Sell(0)

Neutral(0)

Buy(6)

Indicators

Value

Direction

MA5

79.088

Buy

MA10

78.266

Buy

MA20

76.199

Buy

MA50

73.368

Buy

MA100

67.854

Buy

MA200

61.361

Buy

Institutional Confidence

Currency: USD Updated: 2025-11-03

The company’s current institutional recognition score is 5.00, which is lower than the Healthcare Equipment & Supplies industry's average of 6.39. The latest institutional shareholding proportion is 59.17%, representing a quarter-over-quarter decrease of 37.90%. The largest institutional shareholder is The Vanguard, holding a total of 559.40K shares, representing 4.40% of shares outstanding, with 4.14% increase in holdings.

Score

Industry at a Glance

Previous score

5.00

Change

Institutional Shareholding

No Data

Shareholder Activity

Name

Shares Held

Chg %

Susi (Roger E)

4.59M

Nine Ten Capital Management LLC

872.00K

BlackRock Institutional Trust Company, N.A.

621.24K

+2.13%

The Vanguard Group, Inc.

Star Investors

559.40K

+1.19%

Renaissance Technologies LLC

Star Investors

491.81K

-1.97%

Copeland Capital Management, LLC

457.92K

-6.65%

Geode Capital Management, L.L.C.

261.39K

+6.52%

BlackRock Financial Management, Inc.

260.47K

-0.84%

Dimensional Fund Advisors, L.P.

215.43K

-2.16%

Ranger Investment Management, L.P.

214.84K

+7.36%

Risk Assessment

Currency: USD Updated: 2025-11-03

The company’s current risk assessment score is 6.94, which is higher than the Healthcare Equipment & Supplies industry's average of 4.57. The company's beta value is 1.04. This indicates that the stock tends to outperform the index during upward trending markets but experiences larger declines during downward trending markets.